A cross-sectional study of nearly 1,300 patients revealed Chinese physicians systematically overestimate the severity of coronary stenosis, perhaps even more so than in the United States, likely leading to many patients being inappropriately treated with percutaneous coronary intervention (PCI).

While a handful of age-old recommendations like eating well and exercising undoubtedly boost a patient’s health profile, there’s one factor nobody can avoid: aging. Chronological age is the primary risk factor for cardiovascular disease (CVD), first author Kristen Nowak, PhD, and colleagues wrote in a recent Hypertension review, and it’s important to take the necessary steps to achieve healthy vascular aging (HVA)—especially if you know you’re at risk for CVD.

DUBLIN — January 16, 2018 — Medtronic plc (NYSE:MDT) today announced that the company's Neurovascular business unit received U.S. Food and Drug Administration (FDA) clearance of the Riptide(TM) Aspiration System, adding a valuable tool to the Acute Ischemic Stroke (AIS) product portfolio.

The risk of another heart attack following percutaneous coronary intervention (PCI) was twice as likely to originate from a previously untreated lesion versus the stented lesion, according to a study of a large Swedish cohort published in the Journal of the American Heart Association.

Employees who struggle to thrive in stressful work situations are more likely to develop diabetes than their relaxed coworkers, Reuters reported this week.

Black men and women who smoke more than one pack of cigarettes a day could be as much as 79 percent more likely to develop diabetes mellitus than those who have never smoked, according to a study published this month in the Journal of the American Heart Association.

As life expectancy continues to expand for cancer patients, clinicians are increasingly dealing with oncological complications like cardiotoxicity, according to a medical team in the Netherlands—and those doctors are met with a paucity of research on the topic.

An update on the 2013 heart failure guidelines released jointly by the American College of Cardiology and the American Heart Association, the new decision pathway aims to guide clinicians through 10 critical issues in treating heart failure with reduced ejection fraction (HFrEF).